End Cash: The amount of cash held by the company for the given period.
Ginkgo Bioworks Holdings, Inc. (DNA) had End Cash of $212.37M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$33.40M |
|
$-80.75M |
|
$7.30M |
|
$26.09M |
|
$104.15M |
|
$-70.75M |
|
$-10.64M |
|
$-81.39M |
|
$-64.98M |
|
$-80.75M |
|
$-80.75M |
|
$-80.75M |
|
$-64.30M |
|
$-70.75M |
|
$-60.48M |
|
55.46M |
|
55.46M |
|
$-1.41 |
|
$-1.41 |
|
| Balance Sheet Financials | |
$471.84M |
|
$167.78M |
|
$647.86M |
|
$1.12B |
|
$95.97M |
|
-- |
|
$515.14M |
|
$611.11M |
|
$508.59M |
|
$451.67M |
|
$508.59M |
|
58.21M |
|
| Cash Flow Statement Financials | |
$-171.06M |
|
$-240.29M |
|
$17.77M |
|
$605.74M |
|
|
End Cash |
$212.37M |
$-393.37M |
|
$81.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
78.14% |
|
-211.86% |
|
-211.86% |
|
-- |
|
-243.72% |
|
-241.80% |
|
$-178.15M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.38 |
|
65.37 |
|
-15.88% |
|
-17.88% |
|
-7.21% |
|
-15.88% |
|
$8.74 |
|
$-3.21 |
|
$-3.08 |
|